Valeo Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.71M Sell
24,798
-2,917
-11% -$201K 0.04% 194
2025
Q1
$1.92M Sell
27,715
-4,519
-14% -$314K 0.05% 165
2024
Q4
$2.77M Sell
32,234
-5,854
-15% -$504K 0.08% 121
2024
Q3
$4.54M Sell
38,088
-469
-1% -$55.8K 0.13% 79
2024
Q2
$5.5M Buy
38,557
+1,041
+3% +$149K 0.17% 66
2024
Q1
$4.74M Buy
37,516
+11,547
+44% +$1.46M 0.17% 62
2023
Q4
$2.69M Buy
25,969
+2,632
+11% +$272K 0.11% 108
2023
Q3
$2.12M Buy
23,337
+6,191
+36% +$563K 0.1% 119
2023
Q2
$1.39M Sell
17,146
-40
-0.2% -$3.24K 0.06% 167
2023
Q1
$1.37M Buy
17,186
+6,494
+61% +$517K 0.07% 179
2022
Q4
$724K Buy
10,692
+4,926
+85% +$333K 0.04% 232
2022
Q3
$287K Sell
5,766
-936
-14% -$46.6K 0.02% 355
2022
Q2
$373K Sell
6,702
-4,474
-40% -$249K 0.02% 297
2022
Q1
$621K Buy
11,176
+3,716
+50% +$206K 0.03% 270
2021
Q4
$418K Buy
7,460
+240
+3% +$13.4K 0.02% 339
2021
Q3
$347K Buy
+7,220
New +$347K 0.02% 353
2021
Q2
Sell
-26,166
Closed -$882K 1278
2021
Q1
$882K Buy
26,166
+252
+1% +$8.49K 0.04% 182
2020
Q4
$905K Buy
25,914
+22,024
+566% +$769K 0.05% 167
2020
Q3
$135K Sell
3,890
-184
-5% -$6.39K 0.01% 402
2020
Q2
$133K Buy
4,074
+2,466
+153% +$80.5K 0.01% 403
2020
Q1
$48K Buy
1,608
+246
+18% +$7.34K 0.01% 597
2019
Q4
$39K Buy
1,362
+146
+12% +$4.18K ﹤0.01% 730
2019
Q3
$31K Sell
1,216
-42
-3% -$1.07K ﹤0.01% 721
2019
Q2
$32K Buy
1,258
+1,052
+511% +$26.8K ﹤0.01% 716
2019
Q1
$5K Sell
206
-20
-9% -$485 ﹤0.01% 1168
2018
Q4
$5K Sell
226
-1,006
-82% -$22.3K ﹤0.01% 1077
2018
Q3
$27K Buy
1,232
+524
+74% +$11.5K ﹤0.01% 672
2018
Q2
$17K Hold
708
﹤0.01% 805
2018
Q1
$17K Sell
708
-26
-4% -$624 ﹤0.01% 762
2017
Q4
$20K Buy
734
+528
+256% +$14.4K ﹤0.01% 663
2017
Q3
$5K Buy
+206
New +$5K ﹤0.01% 871